• LAST PRICE
    1.8212
  • TODAY'S CHANGE (%)
    Trending Down-0.0288 (-1.5568%)
  • Bid / Lots
    1.8200/ 38
  • Ask / Lots
    1.8300/ 24
  • Open / Previous Close
    1.8500 / 1.8500
  • Day Range
    Low 1.8011
    High 1.8600
  • 52 Week Range
    Low 1.5000
    High 8.3300
  • Volume
    303,074
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.85
TimeVolumeCRBU
09:32 ET305041.83
09:34 ET174241.83
09:36 ET504161.815
09:38 ET114481.82
09:39 ET3001.825
09:41 ET6041.8295
09:43 ET32371.82
09:45 ET37031.82
09:48 ET208541.825
09:50 ET32001.85
09:52 ET14801.84
09:54 ET3001.83
09:56 ET14001.835
09:57 ET1001.84
09:59 ET111941.83
10:01 ET3731.835
10:03 ET56711.845
10:06 ET12001.84
10:08 ET3001.84
10:10 ET133101.83
10:12 ET116541.83
10:14 ET8001.85
10:15 ET6251.85
10:19 ET66001.8471
10:21 ET1001.845
10:24 ET3491.845
10:26 ET4251.85
10:28 ET70991.855
10:30 ET20081.845
10:32 ET5001.85
10:33 ET34951.825
10:35 ET5001.825
10:37 ET3001.825
10:39 ET96221.81
10:42 ET41021.825
10:44 ET6001.825
10:46 ET3001.825
10:48 ET52771.825
10:50 ET3351.824
10:51 ET4311.8289
10:53 ET11021.82
10:55 ET21601.82
10:57 ET2001.815
11:00 ET53631.82
11:02 ET17981.82
11:06 ET12001.815
11:08 ET1001.82
11:09 ET30331.825
11:11 ET5001.825
11:13 ET3001.8299
11:15 ET4001.8288
11:20 ET22161.815
11:22 ET62951.815
11:26 ET3001.815
11:27 ET8401.815
11:29 ET2001.815
11:31 ET10331.815
11:33 ET1001.81
11:36 ET14501.8199
11:38 ET4001.815
11:40 ET2001.815
11:42 ET31291.815
11:44 ET1001.815
11:45 ET36221.825
11:47 ET2461.8289
11:51 ET2001.8212
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRBU
Caribou Biosciences Inc
167.2M
-1.3x
---
United StatesCGEN
Compugen Ltd
155.8M
-16.2x
---
United StatesCLLS
Cellectis SA
151.3M
-1.0x
---
United StatesMRSN
Mersana Therapeutics Inc
230.6M
-2.2x
---
United StatesNBTX
Nanobiotix SA
231.3M
-4.1x
---
United StatesELUT
Elutia Inc
129.8M
-1.3x
---
As of 2024-10-10

Company Information

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its genome-editing platform, including its Cas12a chRDNA technology, enables precision to develop cell therapies that are armored to potentially improve antitumor activity. Its pipeline includes three clinical-stage allogeneic cell therapies from its chimeric antigen receptor (CAR)-T (CAR-T) cell platform targeting the treatment of hematologic malignancies. CB-010 is the lead product candidate from its allogeneic CAR-T cell therapy platform and is being evaluated in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL). Its second product candidate, CB-011, is being evaluated in patients with relapsed or refractory multiple myeloma (r/r MM) in the CaMMouflage phase I trial. CB-012 is its third product candidate.

Contact Information

Headquarters
2929 7TH STREET, STE 120BERKELEY, CA, United States 94710
Phone
510-982-6030
Fax
302-531-3150

Executives

Independent Chairman of the Board
Andrew Guggenhime
President, Chief Executive Officer, Co-Founder, Director
Rachel Haurwitz
Interim Principal Financial Officer and Interim Principal Accounting Officer
Ryan Fischesser
Chief People Officer
Reigin Zawadzki
Chief Technology Officer
Tim Kelly

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$167.2M
Revenue (TTM)
$33.1M
Shares Outstanding
90.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.39
Book Value
$4.17
P/E Ratio
-1.3x
Price/Sales (TTM)
5.0
Price/Cash Flow (TTM)
---
Operating Margin
-427.56%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.